Breaking News
Tuesday , October 24 2017
Home / Business / RBI restricts foreign investors from buying in Claris Lifesciences

RBI restricts foreign investors from buying in Claris Lifesciences

The Reserve Bank of India (RBI) has restricted the Foreign Institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs) in Claris Lifesciences as the foreign investors have crossed the overall limit of 24% of paid-up capital of the company.

RBI monitors ceilings on FII/NRI/PIO investments in Indian companies on a daily basis.

Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly- owned subsidiary dealing in Speciality Injectables business and has a minority stake in Claris Otsuka.

Loading...

About editor